About CHIMagents
CHIMagents was established in 2019 and is based in Guildford, United Kingdom. Operations are centered in the pharmaceutical sector, with a focus on manufacturing potential antiviral drugs and vaccines for testing. The company is led by co-founders Martin Schutten and Adrian Wildfire, the latter serving as CEO. Activities support antiviral research through production of these specialized products in a controlled environment.
- Headquarter Guildford, United Kingdom
- Founders Martin Schutten, Adrian Wildfire
- SectorsHealthcare
- Website chimagents.com
- Social LinkedIn X
- Acquired by Open Orphan (Jul 2020)
- Legal Name Hvivo Services Limited
- Investors
- Acquired byOpen Orphan
(Jul 2020)
Investors in CHIMagents
CHIMagents has secured backing from 1 investor. Prominent investors backing the company include Open Orphan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of testing vaccines & antivirals and CRO pharmaceutical services | 2017 | openorphan.com | London, United Kingdom |
Investor details for CHIMagents
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CHIMagents
2 people are tracked at CHIMagents (2 in leadership).
| Name | Role | Group |
|---|---|---|
Martin Schutten | Co-Founder | Leadership |
Adrian Wildfire | Co-Founder & CEO | Leadership |
Complete people profiles for CHIMagents
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CHIMagents
2 dated milestones of CHIMagents across 1 years, from founding to its latest funding, stage changes and deals.
- Founded CHIMagents is founded.
- Exit Acquired by Open Orphan.
Similar companies to CHIMagents
10 companies that operate in the same segment as CHIMagents (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CHIMagents
CHIMagents was founded in 2019.
CHIMagents is headquartered in Guildford, United Kingdom.
Adrian Wildfire is the current CEO of CHIMagents. They have also founded this company.
CHIMagents was established in 2019 and is based in Guildford, United Kingdom. Operations are centered in the pharmaceutical sector, with a focus on manufacturing potential antiviral drugs and vaccines for testing. The company is led by co-founders Martin Schutten and Adrian Wildfire, the latter serving as CEO. Activities support antiviral research through production of these specialized products in a controlled environment.
CHIMagents has 1 investor. Key investors include Open Orphan.
CHIMagents operates through Hvivo Services Limited.
Yes. CHIMagents was acquired by Open Orphan in July 2020.